Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sir Andrew Dillon Standing Down As Head Of England’s NICE After 20 Years

Executive Summary

Sir Andrew Dillon is stepping down from what has been described as one of the most challenging and potentially controversial roles in British public life.

You may also be interested in...



England’s NICE To Find New Chief As Leng Announces Retirement

The top job at the National Institute for Health and Care Excellence has been described as one of the most challenging and potentially controversial roles in British public life.

England’s NICE To Find New Chief As Leng Announces Retirement

The top job at the National Institute for Health and Care Excellence has been described as one of the most challenging and potentially controversial roles in British public life.

People Round-Up: All Change At UK Agencies As Brexit Looms

The head of the UK’s health technology assessment body NICE is stepping down, while the country’s medicines agency, the MHRA, will have an interim chief in the run-up to the UK’s planned Brexit from the European Union on 31 October.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS140719

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel